Gonorrhoea: tackling the global epidemic in the era of rising antimicrobial resistance

Jason J Ong; Teodora Wi; Gwenda Hughes; Deborah A Williamson; Philippe Mayaud; Eric P F Chow

doi:10.1071/SH19121

Gonorrhoea: tackling the global epidemic in the era of rising antimicrobial resistance

Sex Health. 2019 Sep;16(5):397-400. doi: 10.1071/SH19121.

Authors

Jason J Ong¹, Teodora Wi², Gwenda Hughes³, Deborah A Williamson⁴, Philippe Mayaud⁵, Eric P F Chow⁶

Affiliations

¹ Central Clinical School, Monash University, Melbourne, Vic. 3053, Australia; and Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; and Corresponding author. Email: jong@mshc.org.au.
² Department of Reproductive Health and Research, World Health Organization, Geneva 1211, Switzerland.
³ National Infection Service, Public Health England, Colindale NW9 5EQ, UK.
⁴ Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Vic. 3000, Australia.
⁵ Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
⁶ Central Clinical School, Monash University, Melbourne, Vic. 3053, Australia; and Melbourne Sexual Health Centre, Alfred Health, Carlton, Vic. 3053, Australia.

PMID: 32172790
DOI: 10.1071/SH19121

Abstract

This Special Issue of Sexual Health aims to collate the latest evidence base focussed on understanding the current epidemic and transmission of gonorrhoea, choice of treatment, molecular epidemiology application, concerns about antimicrobial resistance and alternative prevention and control for gonorrhoea.

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Drug Resistance, Bacterial
Epidemics / prevention & control
Epidemics / statistics & numerical data
Global Health
Gonorrhea / drug therapy
Gonorrhea / epidemiology
Gonorrhea / prevention & control*
Humans
Neisseria gonorrhoeae / drug effects

Substances

Anti-Bacterial Agents

Grants and funding

001/WHO_/World Health Organization/International